Skip to main content
Clinical Trials/CTRI/2023/02/050139
CTRI/2023/02/050139
Not yet recruiting
Phase 2

A study to evaluate the efficacy of the test product in providing long-term relief from Dental problems

nilever Industries Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
nilever Industries Pvt Ltd
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
nilever Industries Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • The subject demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent.
  • Satisfactory oral soft tissue examination. absence of any abnormal oral soft tissue condition noted by the Principal Investigator,
  • Be aged 18 \- 65 years, of any sex and in good general health.
  • Availability for the three\-month duration of the study and for all study visits.
  • Be willing and physically able to carry out all study procedures.
  • Be willing to give written informed consent, complete a medical history form and be screened by the Study Dentist.
  • Minimum of 20 uncrowned permanent natural teeth including 5 teeth (excluding third molars).
  • Plaque Index (PI) \>\= 2 by the Turesky Modification of the Quigley\-Hein Plaque Index at baseline.
  • Have initial mean Gingivitis index \>\= 1\.2 as determined by the use of the Loe and Silness Gingival Index at screening and baseline.
  • With normal brushing behaviour/habit, e.g. self\-reported brushing more than 1 minute, twice daily (morning/evening).

Exclusion Criteria

  • Regular (everyday) betel leaf eater (pan) and tobacco user,
  • Use of chlorhexedine mouth rinse. Hydrogen Peroxide Mouth Wash and Herbal Drinks (Fresh vegetable and Fruit drinks)
  • Medical condition and/or regular use of any medication which might affect the outcome of the study. as determined by the study dentist, principally a course of anti\-inflammatory, antimicrobial or statin drugs.
  • Not have had a prophylaxis in the previous month or have one scheduled prior to the end of the study.
  • Pregnant women or women who are breastfeeding. Self\-reported pregnancy.
  • Subjects scheduled for medical or dental procedures for the duration of the study.
  • Full or partial dentures wearers.
  • Current orthodontic.
  • Have oral piercings
  • Smokers or those who have smoked within 3 months of screening, including e\-cigarettes or those who use chewing tobacco.

Outcomes

Primary Outcomes

Not specified

Similar Trials